Osteoarthritis
Osteoarthritis (OA) is a degenerative joint disease characterized by the breakdown of joint cartilage and underlying bone, leading to symptoms like joint pain, stiffness, swelling, and decreased range of motion, most commonly affecting the fingers, thumbs, knees, hips, neck, and lower back. Risk factors include joint injury, obesity, aging, misaligned joints, and family history, with symptoms typically progressing slowly and potentially interfering with daily activities.
Health Outcomes
- Activated Wnt/Beta-Catenin Signaling
- Beneficial Clinical Effects
- Changed Leukocyte Telomere Length
- Changed Walking Cadence
- Decreased Vastus Medialis Thickness
- Duration of Symptoms
- Elevated Serum Substance P Levels
- Enhanced Anti-inflammatory Properties
- Enhanced Anti-inflammatory Response
- Enhanced Antioxidant Enzyme Activity
- Enhanced Cell Viability Under Oxidative Stress
- Enhanced Inflammation Resolution
- Enhanced Inflammatory Response
- Improved 6-Meter Walk Performance
- Improved Activities of Daily Living
- Improved Agility Performance
- Improved Aging-Related Changes
- Improved Antioxidant and Anti-Inflammatory Response
- Improved Barthel Index Score
- Improved Bone Health
- Improved Daily Activity Participation
- Improved Distance Traveled
- Improved Ease of Use
- Improved Enjoyment of Life
- Improved Exercise Function
- Improved Exercise Performance
- Improved Five Times Sit-to-Stand Time
- Improved Function Score
- Improved Functional Outcome
- Improved Functional Recovery
- Improved Gait Speed
- Improved General Health Perception
- Improved Global Evaluation of Patient Score
- Improved Global Quality of Life
- Improved Global Symptom
- Improved Health in Elderly Populations
- Improved Isokinetic Strength
- Improved Joint Function
- Improved KOA Symptoms
- Improved Knee Extensor Strength
- Improved Knee Joint Extensor Strength
- Improved Knee Muscle Strength
- Improved Leg Press Strength
- Improved Leg Strength
- Improved Lower Body Endurance
- Improved Lower Body Power
- Improved Lower Body Strength
- Improved Lower Limb Peak Power
- Improved Lower-Body Strength and Power
- Improved Maximal Power
- Improved Maximal Walking Performance
- Improved Mechanical Properties
- Improved Orthopedic Function
- Improved Overall Health
- Improved Overall Symptom Relief
- Improved Overall Symptoms
- Improved Pain Intensity
- Improved Pain Management
- Improved Pain Scale
- Improved Pain Score
- Improved Pain Threshold
- Improved Patient Global Assessment
- Improved Patient Global Impression of Change (PGI-C) Scores
- Improved Patient Satisfaction
- Improved Physical Domain Score
- Improved Physical Function
- Improved Physical Health-Related Quality of Life
- Improved Physical Mobility
- Improved Physical Performance
- Improved Physical Quality of Life
- Improved Physical Role Limitation
- Improved Presenteeism
- Improved Pressure Pain Threshold
- Improved Quadriceps Endurance
- Improved Quadriceps Function
- Improved Quadriceps Strength
- Improved Quality of Life
- Improved Radiographic Success
- Improved Self-assessed Disability
- Improved Serum Hyaluronan Levels
- Improved Specific Elements Within Assessed Measures
- Improved Standing Balance
- Improved Stiffness
- Improved Strain Index
- Improved Symptom Control in Degenerative Joint Disease
- Improved Symptom Relief
- Improved Symptom Score
- Improved Symptoms
- Improved Tolerance
- Improved Vertical Jump Performance
- Improved Walking Ability
- Improved Walking Distance
- Improved Walking Speed
- Improved Wall-Squat Time
- Improved Western Ontario and McMaster Universities Osteoarthritis Index Total Score
- Increase in Persistent Diseased Sites
- Increased Analgesic Capacity
- Increased Anti-inflammatory Cytokines
- Increased Antioxidant Activity
- Increased Body Mass Index
- Increased Body Weight
- Increased Collagen Synthesis
- Increased EGF Level
- Increased Femoral Neck Bone Mineral Density
- Increased Hyaluronic Acid Molecular Weight
- Increased Hyaluronic Acid Production
- Increased Interleukin-1 Beta Production
- Increased Mineralized Matrix Deposition
- Increased Muscle Cross-Sectional Area
- Increased Osteoprotegerin Immunostaining
- Increased Pain
- Increased Pain-Free Days
- Increased Perceived Pain
- Increased Physical Activity
- Increased Plasma Vitamin K Levels
- Increased Walking Speed
- Maintained Morphological Integrity
- Maintained Physical Activity Level
- Maintained Physical Performance
- Maintained Vigorous Locomotion
- Modulated Nociceptive Signaling
- No Clear Clinical Benefit
- No Clear Effect on Systemic Inflammation
- No Conclusive Efficacy
- No Conclusive Long-Term Clinical Benefit
- No Difference in Adverse Events
- No Significant Change in Hip Joint Bone Mineral Density
- No Significant Change in Tumor Necrosis Factor Alpha Levels
- Normalized Serum IL-1β Levels
- Reduced Aging-related Changes
- Reduced Analgesic Usage
- Reduced Analgesic Use
- Reduced Arthritis Incidence
- Reduced Arthritis Score
- Reduced Arthritis Severity
- Reduced Arthritis Symptoms
- Reduced Average Pain
- Reduced Bodily Pain
- Reduced COX-2 Levels
- Reduced Cadence
- Reduced Cellular Senescence
- Reduced Clinical Symptoms of Arthritis
- Reduced Collagen Secretion
- Reduced Cyclooxygenase-2 Levels
- Reduced Disability
- Reduced Discomfort
- Reduced Disease Severity
- Reduced Hyaluronidase Activity
- Reduced IL-1β Levels
- Reduced Inflammation
- Reduced Inflammatory Pathways
- Reduced Interference Score
- Reduced Interference with Daily Life
- Reduced Interleukin-1β Levels
- Reduced Interleukin-6 Levels
- Reduced Joint Damage
- Reduced Joint Inflammation
- Reduced Joint Swelling
- Reduced Joint Tenderness
- Reduced Knee Pain
- Reduced Locomotor Impairment
- Reduced Mean Total Severity per Day in Reported Episodes
- Reduced Opioid Consumption
- Reduced Overall Symptom Score
- Reduced Pain
- Reduced Pain Assessment Score
- Reduced Pain During Movement
- Reduced Pain Frequency
- Reduced Pain Intensity
- Reduced Pain Levels
- Reduced Pain Scale
- Reduced Pain Score
- Reduced Pain Sensitivity
- Reduced Pain Severity
- Reduced Pain Symptom Score
- Reduced Pain Symptoms
- Reduced Pain-Related Disability
- Reduced Painkiller Consumption
- Reduced Paw Volume
- Reduced Physical Activity
- Reduced Postoperative Fatigue
- Reduced Postoperative Pain
- Reduced Proinflammatory Mediators
- Reduced Quadriceps Muscle Cross-Sectional Area
- Reduced Release of Inflammatory Mediators (TNF-α, IL-6, IL-1β, IL-10)
- Reduced Senescence-Associated Secretory Phenotype
- Reduced Serum Collagen Type II C-Telopeptide (sCTX-II)
- Reduced Soreness
- Reduced Standard Care Medication Need
- Reduced Stiffness
- Reduced Substance P Levels
- Reduced Surface Skewness
- Reduced Swelling
- Reduced Swimming Time
- Reduced Symptom Severity Scale Score
- Reduced TRPV1 Activation
- Reduced Total Analgesic Dosage
- Reduced Treatment Costs
- Reduced WOMAC Function Score
- Reduced WOMAC Pain Score
- Reduced Walking Time
- Reduced Worst Pain
- Slowed Progression of Knee Osteoarthritis
- Strengthened Musculoskeletal System
- Supported Physiological Function in Elderly
- Unchanged Biochemical Parameters
- Unchanged Symptom Severity
- Upregulated Macrophage Inhibitory Factor
- Well-Tolerated Supplementation